Operating in Japan and the US, Saisei Ventures partners with entrepreneurs to develop and implement business strategies that generate strong proof of concept, clinical validation, and market value. They aim to link the life science markets of Japan and the US, leveraging the advantages of each ecosystem. Saisei Ventures invests in early-stage companies and ideas with the goal of improving health outcomes. They work with select researchers and companies to accelerate global innovation in the pharmaceuticals and biotechnology sectors. Saisei Bioventures, managed by Saisei Ventures, is a 2021 vintage early-stage venture capital fund based in Boston, Massachusetts, investing in the United States, Canada, and Japan.